Related Experiment Video
Updated: May 24, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Right bundle branch block is not a predictor of coronary artery disease
Amir Farhang Zand Parsa1, Ladan Haghighi
1Department of Cardiology, Imam Khomeini Medical Center, Tehran University of Medical Sciences, Iran. zandparsa@tums.ac.ir
Insights
Right bundle branch block (RBBB) does not predict coronary artery disease (CAD) presence or severity in suspected CAD patients. However, RBBB may indicate more severe stenosis in the left coronary system, despite no overall association with CAD extent.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Electrocardiography
Background:
- Right bundle branch block (RBBB) is a known predictor of poor outcomes in acute myocardial infarction.
- The prognostic value of RBBB in patients with suspected coronary artery disease (CAD) remains unclear.
- The association between RBBB, CAD incidence, and stenosis severity is not well-established.
Purpose of the Study:
- To investigate the relationship between RBBB and the presence and severity of CAD in patients with suspected CAD.
- To assess if RBBB influences the degree of coronary artery stenosis.
Main Methods:
- Retrospective analysis of 172 patients with RBBB and 174 with normal resting ECG.
- Coronary artery disease severity quantified using the Gensini score based on angiographic findings.
- Statistical analysis to determine associations between RBBB, CAD presence, and Gensini score.
Main Results:
- Prevalence of CAD was 77.3% in the RBBB group versus 70.1% in the normal ECG group (P=0.13).
- No significant association was found between RBBB and overall Gensini score (OR=0.87, P=0.62).
- Male gender and diabetes mellitus were associated with higher Gensini scores (P<0.0001 for both).
- RBBB showed association with increased stenosis severity in the left coronary system (LAD & LCX).
Conclusions:
- RBBB is not associated with the overall presence or severity of coronary artery disease in patients with suspected CAD.
- While RBBB may correlate with more severe stenosis in specific left coronary arteries, it does not predict overall CAD burden.
- Further research is needed to clarify the prognostic implications of RBBB in suspected CAD.
Abstract:
Right bundle branch block (RBBB) is considered as an important predictor of poor outcome in patients with acute myocardial infarction, but the prognostic implication of RBBB in patients with suspected coronary artery disease (CAD) is unclear. Furthermore, the association between RBBB and incidence of CAD also its influence on the severity of stenosis in coronary arteries has not been established. This study was designed to assess the relationship between RBBB and the presence and the severity of CAD in patients with suspected CAD. The study population consisted of 172 patients with RBBB and 174 patients with normal resting electrocardiography (ECG). Severity of CAD was defined as estimated Gensini score according to the degree, quantity and distribution of lesions in angiographic study. According to our study based on angiographic investigations, in patients with RBBB the prevalence of CAD was 77.3 percent versus 70.1 percent in patients with normal resting ECG (P=0.13). Also, there was no significant association between the presence of RBBB and magnitude of Gensini score (OR=0.87, P=0.62). However, male gender and history of diabetes mellitus were associated with higher Gensini score (OR=3.41; 95% CI: 1.96-5.93, P<0.0001 and OR=3.22; 95% CI: 1.77-5.87, P<0.0001 respectively). This study suggests that although RBBB was associated with more severity of stenosis in left coronary system (LAD&LCX), but as a whole there was no association between RBBB and the presence and severity of CAD.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Heart Failure Drugs: β-Blockers
Acute Coronary Syndrome III: Diagnostic Studies
